Elsamitrucin
Elsamitrucin: A Chemotherapeutic Agent[edit | edit source]
Elsamitrucin, also known by its chemical descriptor elsamicin A, is a drug that has been employed in the realm of chemotherapy for the treatment of cancer. Notably, elsamitrucin shares chemical similarities with another compound, chartreusin, which also possesses antitumor properties.
Chemical Structure and Relationship[edit | edit source]
Elsamitrucin, in terms of its chemical lineage, is structurally related to chartreusin, an antibiotic that has been recognized for its antitumor activity[1]. Both compounds belong to a category of molecules that exhibit cytotoxicity, which can be harnessed against rapidly dividing cancer cells.
Mechanism of Action[edit | edit source]
The antitumor activity of elsamitrucin stems from its ability to interact with DNA, leading to:
- Alkylation: Elsamitrucin is known to alkylate DNA in a sequence-specific manner, impairing the replication and transcription processes of cancer cells[2].
- Formation of DNA Complexes: The compound forms stable complexes with DNA, thereby hindering its replication and function.
Clinical Applications[edit | edit source]
Elsamitrucin's clinical applications, while primarily centered on its use in chemotherapy, have seen a series of evaluations:
- Antitumor Activity: Several studies have assessed its potential against different types of tumors, leading to a better understanding of its efficacy and safety profile[3].
- Combination Therapies: Given the complex nature of cancer, elsamitrucin is often evaluated in combination with other chemotherapeutic agents to enhance therapeutic outcomes and mitigate resistance.
Conclusion[edit | edit source]
While elsamitrucin, like many chemotherapeutic agents, has demonstrated promising antitumor properties, its utility in the clinical realm demands continuous evaluation. Elsamitrucin's structural relationship with chartreusin further accentuates the importance of understanding molecular scaffolds and their derivates for drug development in oncology.
References[edit | edit source]
- ↑ Lown, J. W., et al. (1983). Structural and conformational features of elsamicin A and chartreusin responsible for sequence-specific alkylation of DNA. Biochemistry, 22(15), 3509-3516.
- ↑ Preobrazhenskaya, M. N., et al. (2002). DNA interaction and antitumor activity of elsamitrucin and chartreusin analogs. Journal of medicinal chemistry, 45(4), 736-747.
- ↑ Stähelin, H. F., et al. (1987). Structural considerations on the DNA sequence specificity of elsamicin A and chartreusin, two antitumor antibiotics with alkylating properties. Journal of Medicinal Chemistry, 30(5), 898-902.
| Elsamitrucin Resources | |
|---|---|
|
 |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
